Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 5
2013 10
2014 9
2015 7
2016 25
2017 21
2018 29
2019 25
2020 28
2021 19
Text availability
Article attribute
Article type
Publication date

Search Results

148 results
Results by year
Filters applied: . Clear all
Page 1
Ibrutinib and Venetoclax for First-Line Treatment of CLL.
Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda W. Jain N, et al. Among authors: kanagal shamanna r. N Engl J Med. 2019 May 30;380(22):2095-2103. doi: 10.1056/NEJMoa1900574. N Engl J Med. 2019. PMID: 31141631 Clinical Trial.
Digital PCR: Principles and Applications.
Kanagal-Shamanna R. Kanagal-Shamanna R. Methods Mol Biol. 2016;1392:43-50. doi: 10.1007/978-1-4939-3360-0_5. Methods Mol Biol. 2016. PMID: 26843045
Emulsion PCR: Techniques and Applications.
Kanagal-Shamanna R. Kanagal-Shamanna R. Methods Mol Biol. 2016;1392:33-42. doi: 10.1007/978-1-4939-3360-0_4. Methods Mol Biol. 2016. PMID: 26843044
Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML.
Yilmaz M, Alfayez M, DiNardo CD, Borthakur G, Kadia TM, Konopleva MY, Loghavi S, Kanagal-Shamanna R, Patel KP, Jabbour EJ, Garcia-Manero G, Pemmaraju N, Pierce SA, Ghayas I, Short NJ, Montalban-Bravo G, Takahashi K, Assi R, Alotaibi AS, Ohanian M, Andreeff M, Cortes JE, Kantarjian HM, Ravandi F, Daver NG. Yilmaz M, et al. Among authors: kanagal shamanna r. J Hematol Oncol. 2020 Oct 8;13(1):132. doi: 10.1186/s13045-020-00964-5. J Hematol Oncol. 2020. PMID: 33032648 Free PMC article.
Evidence-based review of genomic aberrations in B-lymphoblastic leukemia/lymphoma: Report from the cancer genomics consortium working group for lymphoblastic leukemia.
Akkari YMN, Bruyere H, Hagelstrom RT, Kanagal-Shamanna R, Liu J, Luo M, Mikhail FM, Pitel BA, Raca G, Shago M, Shao L, Smith LR, Smolarek TA, Yenamandra A, Baughn LB. Akkari YMN, et al. Among authors: kanagal shamanna r. Cancer Genet. 2020 May;243:52-72. doi: 10.1016/j.cancergen.2020.03.001. Epub 2020 Mar 21. Cancer Genet. 2020. PMID: 32302940 Review.
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease.
Quesada AE, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Khoury JD, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, Bannon SA, Benton CB, Garcia-Manero G, Kantarjian H, Luthra R, Medeiros LJ, Patel KP. Quesada AE, et al. Among authors: kanagal shamanna r. Am J Hematol. 2019 Jul;94(7):757-766. doi: 10.1002/ajh.25486. Epub 2019 May 7. Am J Hematol. 2019. PMID: 30963592 Free article. Clinical Trial.
Nucleophosmin 1 Mutations in Acute Myeloid Leukemia.
Zarka J, Short NJ, Kanagal-Shamanna R, Issa GC. Zarka J, et al. Among authors: kanagal shamanna r. Genes (Basel). 2020 Jun 12;11(6):649. doi: 10.3390/genes11060649. Genes (Basel). 2020. PMID: 32545659 Free PMC article. Review.
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Sasaki K, Kanagal-Shamanna R, Montalban-Bravo G, Assi R, Jabbour E, Ravandi F, Kadia T, Pierce S, Takahashi K, Nogueras Gonzalez G, Patel K, Soltysiak KA, Cortes J, Kantarjian HM, Garcia-Manero G. Sasaki K, et al. Among authors: kanagal shamanna r. Cancer. 2020 Feb 15;126(4):765-774. doi: 10.1002/cncr.32566. Epub 2019 Nov 19. Cancer. 2020. PMID: 31742675 Free article.
148 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page